DrugPatentWatch Database Preview
Profile for Spain Patent: 2330025
US Patent Family Members and Approved Drugs for Spain Patent: 2330025
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Try a Free Trial | Aug 8, 2028 | Genzyme Corp | CAPRELSA | vandetanib |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |